Cargando…
Sinopharm Vaccine, SARS-CoV-2 Breakthrough Infections and Hemoglobinopathies
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Università Cattolica del Sacro Cuore
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266777/ https://www.ncbi.nlm.nih.gov/pubmed/35865392 http://dx.doi.org/10.4084/MJHID.2022.060 |
| _version_ | 1784743552101646336 |
|---|---|
| author | Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj |
| author_facet | Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj |
| author_sort | Mungmunpuntipantip, Rujittika |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9266777 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Università Cattolica del Sacro Cuore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92667772022-07-20 Sinopharm Vaccine, SARS-CoV-2 Breakthrough Infections and Hemoglobinopathies Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj Mediterr J Hematol Infect Dis Letter to the Editor Università Cattolica del Sacro Cuore 2022-07-01 /pmc/articles/PMC9266777/ /pubmed/35865392 http://dx.doi.org/10.4084/MJHID.2022.060 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj Sinopharm Vaccine, SARS-CoV-2 Breakthrough Infections and Hemoglobinopathies |
| title | Sinopharm Vaccine, SARS-CoV-2 Breakthrough Infections and Hemoglobinopathies |
| title_full | Sinopharm Vaccine, SARS-CoV-2 Breakthrough Infections and Hemoglobinopathies |
| title_fullStr | Sinopharm Vaccine, SARS-CoV-2 Breakthrough Infections and Hemoglobinopathies |
| title_full_unstemmed | Sinopharm Vaccine, SARS-CoV-2 Breakthrough Infections and Hemoglobinopathies |
| title_short | Sinopharm Vaccine, SARS-CoV-2 Breakthrough Infections and Hemoglobinopathies |
| title_sort | sinopharm vaccine, sars-cov-2 breakthrough infections and hemoglobinopathies |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266777/ https://www.ncbi.nlm.nih.gov/pubmed/35865392 http://dx.doi.org/10.4084/MJHID.2022.060 |
| work_keys_str_mv | AT mungmunpuntipantiprujittika sinopharmvaccinesarscov2breakthroughinfectionsandhemoglobinopathies AT wiwanitkitviroj sinopharmvaccinesarscov2breakthroughinfectionsandhemoglobinopathies |